In Re: Gardasil Products Liability Litigation

3:22-md-03036NcwdJan 27, 2023

Full text

UNITED STATES DISTRICT COURT
WESTERN DISTRICT OF NORTH CAROLINA
CHARLOTTE DIVISION
3:22-md-03036-RJC
IN RE: GARDASIL PRODUCTS LIABILITY
LITIGATION
)
)
)
)
)
)
)
MDL No. 3036
THIS DOCUMENT RELATES TO
ALL CASES
)
)
JOINT STIPULATION AND ORDER REGARDING
ALTERNATIVE FOR SERVICE OF PROCESS ON MERCK ENTITIES
1. This Order applies to all actions currently pending in or later transferred to In re Gardasil
Products Liability Litigation (“MDL No. 3036”) by the Judicial Panel on Multidistrict Litigation
(“JPML”) pursuant to its August 4, 2022, Transfer Order, all related actions originally filed in or
removed to this Court, and any “tag-along” actions transferred to this Court by the JPML
subsequent to the filing of the final Transfer Order (collectively “Member Actions”).
2. This Order provides the manner in which Merck entities may be served with process of a
Summons and Complaint that has been properly filed in, removed to, or transferred to MDL No.
3036. This Order does not apply to service of process for lawsuits pending in state court.
3. This Order does not preclude a Plaintiff from serving Merck entities as prescribed in
Federal Rule of Civil Procedure 4.
4. Nothing in this Order may be construed as a waiver or limitation of any rights or defenses
available to Merck.
5. For the sake of efficiency of all parties, Merck has agreed to accept service of a Summons
and Complaint related to a products liability action related to Gardasil and either filed directly into
Case 3:22-md-03036-KDB Document 62 Filed 01/27/23 Page 1 of 2
MDL No. 3036 or transferred into MDL No. 3036, via email at the following email address:
Gardasilservice@merck.com.
6. If service is accomplished via email, the body of the email shall identify by name each
plaintiff named in a Complaint served by that email.
7. If service is accomplished via email, service shall be deemed completed at the time of the
electronic submission, provided there is no email bounce-back within twenty-four (24) hours.
8. Merck’s responsive pleading deadline and related procedures shall be set forth in a separate
Order.
9. Should Merck seek to change the email or method of alternative service set forth above,
counsel for Merck shall promptly advise Plaintiffs’ Liaison and Co-Lead Counsel via email, who
shall notify all Plaintiffs’ counsel of the change. For any change, absent agreement of the parties
or special circumstances, there shall be thirty (30) days before any change in the email or other
method of alternative service is effectuated.
SO ORDERED.
Signed: January 27, 2023
Case 3:22-md-03036-KDB Document 62 Filed 01/27/23 Page 2 of 2

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.